Ignite Creation Date:
2024-05-06 @ 2:39 AM
Last Modification Date:
2024-10-26 @ 11:21 AM
Study NCT ID:
NCT02092324
Status:
COMPLETED
Last Update Posted:
2020-11-16
First Post:
2014-03-18
Brief Title:
Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia
Sponsor:
OHSU Knight Cancer Institute
Organization:
OHSU Knight Cancer Institute
Organization Data
Organization:
OHSU Knight Cancer Institute
Class:
OTHER
Study ID:
IRB00010262
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
OHSU Knight Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Kim-Hien Dao
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
OHSU Knight Cancer Institute
Old Name:
None
Old Organization:
None